Healthcare Holding B.V. Gilde Sells 28,245 Shares of Shoulder Innovations (NYSE:SI) Stock

Shoulder Innovations, Inc. (NYSE:SI) major shareholder Healthcare Holding B.V. Gilde sold 28,245 shares of the stock in a transaction dated Thursday, July 30th. The stock was sold at an average price of $23.36, for a total transaction of $659,803.20. Following the sale, the insider owned 2,352,237 shares in the company, valued at approximately $54,948,256.32. This trade represents a 1.19% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

• On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.73, for a total value of $455,372.82.

Shoulder Innovations Stock Up 1.5%

NYSE:SI opened at $22.72 on Wednesday. The company has a current ratio of 11.81, a quick ratio of 10.04 and a debt-to-equity ratio of 0.11. The stock has a 50 day moving average of $19.50 and a 200-day moving average of $15.92. The firm has a market capitalization of $471.13 million and a PE ratio of -0.14. Shoulder Innovations, Inc. has a 52 week low of $10.92 and a 52 week high of $24.59.

Shoulder Innovations (NYSE:SI) last announced its quarterly earnings results on Wednesday, May 13th. The company reported ($0.41) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.44) by $0.03. The business had revenue of $16.71 million for the quarter. Shoulder Innovations had a negative return on equity of 35.11% and a negative net margin of 81.78%. Analysts predict that Shoulder Innovations, Inc. will post -1.67 EPS for the current year.

Institutional Investors Weigh In On Shoulder Innovations

Hedge funds and other institutional investors have recently modified their holdings of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in Shoulder Innovations in the 3rd quarter valued at about $28,000. Rhumbline Advisers bought a new stake in shares of Shoulder Innovations during the 3rd quarter worth about $54,000. Wells Fargo & Company MN lifted its stake in shares of Shoulder Innovations by 66.3% in the 4th quarter. Wells Fargo & Company MN now owns 5,250 shares of the company’s stock worth $75,000 after acquiring an additional 2,094 shares during the period. Renaissance Technologies LLC bought a new position in shares of Shoulder Innovations in the fourth quarter valued at approximately $176,000. Finally, Blue Trust Inc. acquired a new position in shares of Shoulder Innovations during the first quarter valued at approximately $228,000.

Analysts Set New Price Targets

SI has been the subject of several recent research reports. Piper Sandler restated an “overweight” rating and set a $19.00 price target (up from $18.00) on shares of Shoulder Innovations in a research report on Friday, May 8th. UBS Group initiated coverage on shares of Shoulder Innovations in a research note on Tuesday, July 28th. They set a “buy” rating and a $27.00 target price for the company. Finally, Weiss Ratings raised Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a report on Monday. Six investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Shoulder Innovations presently has a consensus rating of “Moderate Buy” and a consensus target price of $22.00.

About Shoulder Innovations

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.